Recently, the review of [37] shows that the changes in the expression or activity of calcium channels and pumps are relevant for the pathology of cancers (patient samples and cell lines) for instance, in prostate cancer: TRPM8, TRPV6, ORAI1, TRPV2; breast cancer: TRPM8, TRPV6, TRPC6, PMCA1, PMCA2, SPCA2, ORAI1, ORAI3; lung cancer: IP3R2, CACNA2D2, TRPM8, PMCA, SERCA2; colon/colorectal: Cav. Here, TRPM8 is linked to breast cancer.